Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
K

Knight Therapeutics Inc
OTC:KHTRF

Watchlist Manager
Knight Therapeutics Inc
OTC:KHTRF
Watchlist
Price: 4.245 USD Market Closed
Market Cap: $430.3m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

KHTRF Price Targets Summary
Knight Therapeutics Inc

Wall Street analysts forecast KHTRF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KHTRF is 5.802 USD with a low forecast of 4.454 USD and a high forecast of 7.529 USD.

KHTRF Lowest Forecast
Wall Street Target
4.454 USD
5% Upside
KHTRF Average Forecast
Wall Street Target
5.802 USD
37% Upside
KHTRF Highest Forecast
Wall Street Target
7.529 USD
77% Upside
Lowest
Price Target
4.454 USD
5% Upside
Average
Price Target
5.802 USD
37% Upside
Highest
Price Target
7.529 USD
77% Upside
Knight Therapeutics Inc Competitors:
Price Targets
LE
Lands End Inc
3% Upside
LE
Lands End Inc
3% Upside

Revenue
Forecast

93% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
93% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 9 years the compound annual growth rate for Knight Therapeutics Inc's revenue is 93%. The projected CAGR for the next 4 years is 11%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
47% / Year
Estimated Growth
Estimates Accuracy
72%
Average Beat
N/A
Past Growth
47% / Year
Estimated Growth
Estimates Accuracy
72%
Average Beat

The compound annual growth rate of Knight Therapeutics Inc's operating income for the next 4 years is 47%.

What are analyst estimates?

Net Income
Forecast

-21% / Year
Past Growth
69% / Year
Estimated Growth
Estimates Accuracy
35%
Average Beat
-21% / Year
Past Growth
69% / Year
Estimated Growth
Estimates Accuracy
35%
Average Beat

For the last 9 years the compound annual growth rate for Knight Therapeutics Inc's net income is -21%. The projected CAGR for the next 4 years is 69%.

What are analyst estimates?

See Also

Summary
KHTRF intrinsic value, competitors valuation, and company profile.
DCF Valuation
KHTRF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KHTRF stock valuation using valuation multiples.
Wall Street Estimates
KHTRF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KHTRF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KHTRF's stock price target?
Price Target
5.802 USD

According to Wall Street analysts, the average 1-year price target for KHTRF is 5.802 USD with a low forecast of 4.454 USD and a high forecast of 7.529 USD.

What is Knight Therapeutics Inc's Revenue forecast?
Projected CAGR
11%

For the last 9 years the compound annual growth rate for Knight Therapeutics Inc's revenue is 93%. The projected CAGR for the next 4 years is 11%.

What is Knight Therapeutics Inc's Operating Income forecast?
Projected CAGR
47%

The compound annual growth rate of Knight Therapeutics Inc's operating income for the next 4 years is 47%.

What is Knight Therapeutics Inc's Net Income forecast?
Projected CAGR
69%

For the last 9 years the compound annual growth rate for Knight Therapeutics Inc's net income is -21%. The projected CAGR for the next 4 years is 69%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.